Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation-Reference-Cited by-同舟云学术

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Published:2005-04-23 Issue:10 Volume:48 Page:3474-3477
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Coe Jotham W.¹,Brooks Paige R.¹,Vetelino Michael G.¹,Wirtz Michael C.¹,Arnold Eric P.¹,Huang Jianhua¹,Sands Steven B.¹,Davis Thomas I.¹,Lebel Lorraine A.¹,Fox Carol B.¹,Shrikhande Alka¹,Heym James H.¹,Schaeffer Eric¹,Rollema Hans¹,Lu Yi¹,Mansbach Robert S.¹,Chambers Leslie K.¹,Rovetti Charles C.¹,Schulz David W.¹,Tingley F. David¹,O'Neill Brian T.¹

Affiliation:

1. Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm050069n

Reference55 articles.

1. The “Counterblaste to Tobacco” King James, 1604.

2. (b) World Health Organization. Reducing risks, promoting healthy life. In The World Health Report; WHO: Geneva, 2002.

3. Estimates of global mortality attributable to smoking in 2000

4. Mortality in relation to smoking: 50 years' observations on male British doctors

Cited by 841 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats;Frontiers in Molecular Neuroscience;2024-09-05

2. Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds;European Journal of Medicinal Chemistry;2024-09

3. Iridium-catalysed synthesis of C,N,N-cyclic azomethine imines enables entry to unexplored nitrogen-rich 3D chemical space;Nature Synthesis;2024-07-09

4. Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors;Biochemical Pharmacology;2024-07

5. Cytisine for smoking cessation: A 40-day treatment with an induction period;Tobacco Prevention & Cessation;2024-05-27